The pathophysiology of acute respiratory distress syndrome

Respiratory Care Clinics of North America

Volumn 9, Issue 3, 2003, Pages 283-296

  Dechert, Ronald E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHEMOKINE; COLONY STIMULATING FACTOR; CYTOKINE; INTERFERON; TUMOR NECROSIS FACTOR;

BLOOD GAS ANALYSIS; BLOOD VESSEL PERMEABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; GENOMICS; HUMAN; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG DIFFUSION; LUNG EDEMA; LUNG FUNCTION TEST; LUNG INJURY; MOLECULAR MECHANICS; MORTALITY; PATHOPHYSIOLOGY; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME; REVIEW;

EID: 0141926684     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5337(03)00031-5     Document Type: Article

References (69)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7511):319-23.
2. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-8.
3. Matthay MA. Conference summary: acute lung injury. Chest 1999;116(1):119-26.
4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-9.
5. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974;110(5):556-65.
6. Parker JC, Townsley MI, Rippe B, Taylor AE, Thigpen J. Increased microvascular permeability in dog lungs due to high peak airway pressure. J Appl Physiol 1984; 57(6):1809-16.
7. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137(5):1159-64.
8. Corbridge TC, Wood LDH, Crawford GP, Chudoba MJ, Yanos J, Sznajder JI. Adverse effects of large tidal volumes and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990;142(2):311-5.
9. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998;157(6):1721-5.
10. Lamy M, Fallat RJ, Koeniger E, Dietrich HP, Ratliff JL, Eberhart RC, et al. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976;114(2):267-84.
11. Tomashefski JF Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11(4):593-619.
12. Demling RH. The modern version of adult respiratory distress syndrome. Annu Rev Med 1995;46(1):193-202.
13. Ingbar DH. Actue respiratory distress syndrome: mechanisms of repair and remodeling following acute lung injury. Clin Chest Med 2000;21(3):589-616.
14. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27(2):304-12.
15. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982;3(1):35-56.
16. Martin TM, Pistorese B, Chi EY, Goodman RB, Matthay MA. Effect of leukotriene B4 in the human lung: recruitment of neutrophils into the alveolar space without a change in protein permeability. J Clin Invest 1989;84(5):1609-16.
17. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147(1):218-33.
18. Haas CF, Weg JG. Exogenous surfactant therapy: an update. Respir Care 1996;41(5): 397-415.
19. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 1982;70(3):673-83.
20. Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989;140(4):1033-9.
21. Gregory T, Longmore W, Moxley M, Whitsett J, Reed C, Fowler A, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88(6):1976-81.
22. Seeger W, Pison U, Buchhorn R, Oberstacke U, Joka T. Surfactant abnormalities and adult respiratory failure. Lung 1990;(Suppl):891-902.
23. Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruck J, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990;30(1):19-26.
24. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distribution in the adult respiratory distress syndrome. Am Rev Respir Dis 1979;120(5): 1039-52.
25. Ralph DD, Roberton HT, Weaver LJ, Hlastala MP, Carrico CJ, Hudson LD. Distribution of ventilation and perfusion during positive end-expiratory pressure in the adult respiratory distress syndrome. Am Rev Respir Dis 1985;131(1):54-60.
26. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132(3):485-9.
27. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in adult respiratory distress syndrome: association of increased peptide levels in lavage fluid with increased risk of death. Ann Intern Med 1995;122(1):17-23.
28. Chesnutt A, Matthay M, Tibayan F, Clark JG. Early detection of type III procollagen peptide in acute lung injury: pathogenic and prognostic significance. Am J Respir Crit Care Med 1997;156(3):840-5.
29. Baughman RP, Gunther KL, Rashkin MC, Keeton DA, Pattishall EN. Changes in the inflammatory response of the lung during acute respiratory distress syndrome; prognostic indicators. Am J Respir Crit Care Med 1996;154(1):76-81.
30. Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 1998;26(2):369-76.
31. Steinberg KP, Hudson LD. Acute lung injury and acute respiratory distress syndrome: the clinical syndrome. Clin Chest Med 2000;21(3):401-17.
32. McHugh LJ, Milberg JA, Whitcomb ME, Schoene RB, Maunder RJ, Hudson LD. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994;150(1):90-4.
33. Yahav J, Lieberman P, Molho M. Pulmonary function following the adult respiratory distress syndrome. Chest 1978;74(3):247-50.
34. Elliott CG, Morris AH, Cengiz M. Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome. Am Rev Respir Dis 1981;123(5): 492-5.
35. Ghio AJ, Elliott CG, Crapo RO, Berlin SL, Jensen RL. Impairment after adult respiratory distress syndrome: an evaluation based on American Thoracic Society recommendations. Am Rev Respir Dis 1989;139(5):1158-62.
36. Krafft P, Fridrich P, Pernerstorfer T, Fitzgerald RD, Koc D, Schneider B, et al. The acute respiratory distress syndrome. Definitions, severity and clinical outcome; an analysis of 101 clinical investigations. Intensive Care Med 1996;22(6):519-29.
37. Davidson TA, Rubenfeld GD, Caldwell ES, Hudson LD, Steinberg KP. The effect of acute respiratory distress syndrome on long-term survival. Am J Respir Crit Care Med 1999;160(6):1838-42.
38. Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999; 159(6):1849-61.
39. Weinert CR, Gross CR, Kangas JR, Bury CL, Marinelli WA. Health-related quality of life after acute lung injury. Am J Respir Crit Care Med 1997;156(4):1120-8.
40. Schelling G, Stoll C, Hallar M. Health-related quality of life and posttraumatic disorder in survivors of acute respiratory distress syndrome. Crit Care Med 1998;26(4):651-9.
41. Davidson TA, Caldwell ES, Curtis JR, Steinberg KP. Reduced quality of life in survivors of acute respiratory distress syndrome with critically ill control patients. JAMA 1999;281(4):354-60.
42. Hopkins RO, Weaver L, Pope D, Orme JF, Bigler ED, Larson-Lohr V, et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;160(1):60-5.
43. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TM. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153(6):1850-6.
44. Martin TR. Lung cytokines and ARDS. Chest 1999;116(1):1-8.
45. Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury. Chest 1999;116(1):104-10.
46. Parsons PE. Mediators and mechanisms of acute lung injury. Clin Chest Med 2000;21(3):467-76.
47. Papadakos PJ. Cytokines, genes, and ARDS. Chest 2002;121(5):1391-2.
48. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biologic markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997;155(4): 1187-205.
49. Abraham E, Jesmok G, Tudor R, Allbee J, Chang YH. Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 1995;23(8):1319-26.
50. Chollet-Martin S, Jourdin B, Gilbert C, Elbim C, Chaste J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996;154(3):594-601.
51. Petty TL. Indicators of risk, course, and prognosis in adult respiratory distress syndrome (ARDS) [editorial]. Am Rev Respir Dis 1985;132(3):471.
52. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997;111(5):1306-21.
53. Moldawer LL. Biology of proinflammatory cytokines and their antagonists. Crit Care Med 1994;22(1 Suppl):3-7.
54. Grigg JM, Barber A, Silverman M. Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis 1992;145(4):782-6.
55. Humbert M, Delattre RM, Fattal S, Rain B, Cerrina J, Dartevelle P, et al. In situ production of interleukin-6 within human lung allografts displaying rejection or cytomegalovirus pneumonia. Transplant 1993;56(3):623-7.
56. Lindsey HJ, Kisala JM, Ayala A, Lehman D, Herdon CD, Chaudry IH. Pentoxifyllinc attentuates oxygen-induced lung injury. J Surg Res 1994;56(6):543-8.
57. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, Di Francesco C, et al. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 1992;166(4): 731-37.
58. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146(2):427-32.
59. Kurdowska A, Miller EJ, Noble JM, Baughman RP, Matthay MA, Brelsford WG, et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 1996;157(6):2699-706.
60. The ARDS Network Authors for the ARDS Network. Ketoconazole does not reduce mortality in patients with the acute respiratory distress syndrome. JAMA 2000; 283(15):1995-2002.
61. Leikauf GD, McDowell SA, Wesslekamper SC, Hardie WD, Leikauf JE, Korfhagen TR, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002; 121(3):70S-5S.
62. Wong HR. ARDS: the future. Crit Care Clin 2002;18(1):177-96.
63. DeRisi JL, Iyer VR. Genomics and array technology. Cur Opinion Oncology 1999; 11(1):76-9.
64. Albelda SM, Sheppard D. Functional genomics and expression profiling. be there or be square. Am J Respir Cell Mol Biol 2000;23(3):265-9.
65. Lockhart D, Winzeler E. Genomics, gene expression and DNA arrays. Nature 2000;405(6788):827-36.
66. Nadadur SS, Schladweiler MC, Kodavanti UP. A pulmonary rat gene array for screening altered expression profiles in air pollutant-induced lung injury. Inhal Toxicol 2000; 12(12):1239-54.
67. Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000; 9(18):2751-60.
68. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, et al. Polymorphisms of human SP-A, SP-B, and SP-D genes. Association of SP-B Thr131Ile with ARDS. Clin Genet 2000;58(3):181-91.
69. Nogce LM, Dunbar AE, West SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344(8):573-9.